CART19 cells

· Institute of Hematology and Blood Transfusion, Czech Republic

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CART19 cells, covering 2025-01-06 to 2025-01-06. Get the full timeline:

Most recent: Clinical Trial Update: CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma [Phase 1]

See pricing